LNWTC
IDXX icon

Laird Norton Wetherby Trust Company’s Idexx Laboratories IDXX Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
2,927
-14
-0.5% -$7.85K 0.03% 401
2026
Q1 		$1.65M Sell
2,941
-14
-0.5% -$8.98K 0.04% 353
2025
Q4 		$2M Buy
+2,955
New +$2.01M 0.04% 319

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Laird Norton Wetherby Trust Company's IDXX Position: Q2 2026 in Review

Laird Norton Wetherby Trust Company reduced its Idexx Laboratories (IDXX) stake by 0.48% in Q2 2026, selling an estimated $7.85K and leaving 2,927 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #401.

Laird Norton Wetherby Trust Company first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Laird Norton Wetherby Trust Company held 2,927 shares of Idexx Laboratories worth $1.54M as of Q2 2026.
  • Laird Norton Wetherby Trust Company sold 14 Idexx Laboratories shares in Q2 2026, an estimated $7.85K.
  • Idexx Laboratories made up 0.03% of Laird Norton Wetherby Trust Company's portfolio in Q2 2026, its #401 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Laird Norton Wetherby Trust Company's Idexx Laboratories position peaked at $2M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q2 2026, filed 14 Aug 2026.